Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Dysbiosis of the Gut Microbiome in Lung Cancer

In 30 lung cancer patients versus 30 controls, gut bacterial diversity was unchanged but composition differed. Bifidobacterium fell from 4.7 to 1.5 percent and the whole Actinobacteria phylum dropped, while Enterococcus rose from 0.2 to 4.3 percent, marking possible gut biomarkers of lung cancer.

2026-07-05

Gastrointestinal symptoms of long COVID-19 related to the ectopic colonization of specific bacteria that move between the upper and lower alimentary tract and alterations in serum metabolites

In mild COVID-19 patients with gastrointestinal long-COVID symptoms, gut microbes of the Proteobacteria phylum, including Neisseria, Lautropia and Agrobacterium, ectopically colonized the oral cavity and correlated with potentially harmful serum metabolites. Patients without long-COVID symptoms showed little microbiome change.